Gefitinib in advanced breast cancer

被引：0
|
作者：
Rebecca Doherty
机构：
来源：
Nature Clinical Practice Oncology | 2005年 / 2卷 / 10期
关键词：
D O I：
10.1038/ncponc0270
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：484 / 485
页数：1
相关论文
共 50 条
  • [1] Phase II and tumor pharmacodynamic study of gefitinib in patients with advanced breast cancer
    Baselga, J
    Albanell, J
    Ruiz, A
    Lluch, A
    Gascón, P
    Guillém, V
    González, S
    Sauleda, S
    Marimón, I
    Tabernero, JM
    Koehler, MT
    Rojo, F
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (23) : 5323 - 5333
  • [2] Gefitinib has a low clinical benefit rate in advanced breast cancer patients.
    Francis, P
    Green, M
    Gebski, V
    Harvey, V
    Karapetis, C
    Chan, A
    Snyder, R
    Forbes, J
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S193 - S193
  • [3] Gefitinib treatment in hormone-resistant and hormone receptor-negative advanced breast cancer
    Green, M. D.
    Francis, P. A.
    Gebski, V.
    Harvey, V.
    Karapetis, C.
    Chan, A.
    Snyder, R.
    Fong, A.
    Basser, R.
    Forbes, J. F.
    ANNALS OF ONCOLOGY, 2009, 20 (11) : 1813 - 1817
  • [4] Busting the Breast Cancer with AstraZeneca's Gefitinib
    Chemmalar, S.
    Intan Shameha, A. R.
    Che Abdullah, Che Azurahanim
    Ab Razak, Nor Asma
    Yusof, Loqman Mohamad
    Ajat, Mokrish
    Chan, Kim Wei
    Abu Bakar Zakaria, Md Zuki
    ADVANCES IN PHARMACOLOGICAL AND PHARMACEUTICAL SCIENCES, 2023, 2023
  • [5] Gefitinib single drug in treatment of advanced esophageal cancer
    Xu, Yingjun
    Xie, Zhihui
    Shi, Yan
    Zhang, Mengwei
    Pan, Jia
    Li, Yanming
    Lu, Hong
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2016, 12 (08) : 295 - 297
  • [6] Unexpected hepatic toxicity after primary treatment with gefitinib and docetaxel in patients with locally advanced breast cancer.
    Bines, J
    Branco, LGP
    Gomes, CA
    Costa, F
    Barrios, CH
    Martins, RG
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S67 - S67
  • [7] Gefitinib with concurrent chemoradiation in locally advanced head and neck cancer
    Saini, Surendra Kumar
    Srivastava, Shely
    Dixit, Awadhesh Kumar
    GACETA MEXICANA DE ONCOLOGIA, 2016, 15 (03): : 138 - 144
  • [8] A phase II study of gefitinib in patients with advanced thyroid cancer
    Pennell, N. A.
    Daniels, G. H.
    Haddad, R. I.
    Ross, D. S.
    Wirth, L. J.
    Fidias, P. H.
    Temel, J. S.
    Gurubhagavatula, S.
    Clark, J. R.
    Lynch, T. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [9] Gefitinib for advanced non-small cell lung cancer
    Sim, Esther H. A.
    Yang, Ian A.
    Wood-Baker, Richard
    Bowman, Rayleen V.
    Fong, Kwun M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (01):
  • [10] Randomized trial of gefitinib for advanced lung cancer closed early
    不详
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (10) : 712 - 712
12345